Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies

BACKGROUND: Cancer treatment is increasingly dependent on biomarkers for prognostication and treatment selection. Potential biomarkers are frequently evaluated in prospective-retrospective studies in which biomarkers are measured retrospectively on archived specimens after completion of prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wei, Zhang, Zhiwei, Krushkal, Julia, Liu, Aiyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977501/
https://www.ncbi.nlm.nih.gov/pubmed/33740890
http://dx.doi.org/10.1186/s12874-021-01239-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977501/
https://www.ncbi.nlm.nih.gov/pubmed/33740890
http://dx.doi.org/10.1186/s12874-021-01239-4

Ejemplares similares